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Materials and Methods: Fourteen patients treated atour facility with 
passively scattered proton beams were selected. Aperture areas 
ranged from ~3 to ~35 cm2. Aperture sizes < 3 cm2 were not 
considered in this study because aperture scattering effects might 
outweigh effects from patient heterogeneities. Dose distributions 
predicted by our pencil beam (PB) algorithm were verified against MC 
dose calculations using TOPAS—a TOol for PArticle Simulation layered 
on top of GEANT4. Open field dosimetry was corrected based on the 
clinical guidelines for small fields to consider aperture scattering and 
dose equilibrium. DVHs were analyzed and differences in the dose to 
the 50% of the GTV (D50) were assessed on a field-by-field basis. We 
developed a simple and fast methodology to quantify the tissue 
inhomogeneity traversed by a single beam using a heterogeneity index 
(HI). The implementation was based on the dose calculation approach 
taken by our PB algorithm. Finally, we evaluated the potential 
correlation between the errors made by our PB algorithm in D50 for 
each field and the level of tissue heterogeneity traversed by the 
proton beam given by HI. 
Results: Discrepancies up to 5.4% were found in D50 ([D50PB—D50MC]/ 
D50MC). The discrepancies found for each field exhibited a strong 
correlation to their associated HI-values (Spearman's ρ = 0.8, p 
<0.0001); the higher the level of tissue heterogeneities for a 
particular field, the larger the dosimetric error by the analytical 
algorithm. With the established correlation a threshold for HI could be 
set by choosing a tolerance level; requiring an absolute difference for 
D50 < 2.5% for clinical routines suggests recalculation ofpatient 
treatments for HIt >> 1.7. 
 
  
Conclusions: The HI as defined in this study appeared to be a good 
indicator for theaccuracy of proton field delivery in terms of GTV 
prescription dose coverage. Each HI-value was obtained in less than 3 
minutes allowing the implementation of this methodology in the 
clinical routine. For HI-values exceeding the threshold, either a 
change in beam direction (if feasible) or a recalculationof the dose 
with Monte Carlo would be highly recommended.  
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Purpose/Objective: To validate experimentally a GATE/GEANT4-
based(G4) Monte Carlo (MC) model in heterogeneous media for 
dedicated pencil beam scanning in proton therapy. Comparisons 
between measurements and MC simulations using G4 and PENELOPE-
proton are presented. A comparison against analytical modeling from 
commercial TPS is also investigated. This work evaluates the impact 
of heterogeneities on range prediction, beam shape and depth dose 
changes. 
Materials and Methods: The MC model for pencil beam based on G4 
has been validated in water and PMMA phantoms (Grevillot et al Phys. 
Med. Biol.(2011)) reproducing pristine Bragg peaks for a series of 
individual energies (from 100 to 226.7 MeV) with 0.7 mm range and 
0.2 mm spot size accuracy. The same optical model was implemented 
in PENELOPE-proton. In order to validate the beam model in 
heterogeneous media, phantoms made of stacked slabs with different 
densities and known compositions were used. Two experimental test 
cases including solid water (SW), lung (LN-300) and bone (SB3) tissue-
equivalent material were investigated. Depth-dose distributions for a 
monoenergetic single spot and 10x10cm² composite fields were 
measured using Gafchromic EBT3 films and the ionization chamber 
(IC) PPC05 in all configurations. To measure accurately the Bragg peak 
position, a stack of films of 2x2cm² was inserted in the last 
centimeter of the proton range. 
Results: Figure 1 shows results for one heterogeneous configuration. 
All doses-to-medium were converted to dose to water using stopping 
power ratios. Dose distributions were arbitrarily normalized in the 
middle of the second SW region. Bragg peak positions are reproduced 
by MC simulations within 1mm in both configurations (Table 1). IC 
measurements, G4 (binary-cascade) and PENELOPE-proton simulations 
are within 2%/2 mm. Point-to-point mean difference of 1.2% is 
observed between G4 (precompound) and measurement in the first 15 
cm of the phantom and increased to 7.2% after bone insert until 
286.5mm depth. In lung and bone slabs, EBT3 films and G4 binary-
cascade are inagreement within 0.77% while a mean point-to-point 
difference up to 1.26% is observed with G4 precompound model. The 
uncertainty (1σ) on EBT3 films was evaluated to be at 2.75% which 
included readout process and dose calibration against IC (TRS-398). A 
statistical uncertainty of 0.1% was achieved for MC simulations. 
 
 
  
Conclusions: The Bragg peak position is predicted with 1mm precision 
for all MC simulations, even though ionization potential values for 
phantom slabs were calculated using classical additive rules. G4/GATE 
beam model reproduce depth-dose behavior of proton transport 
regarding both IC and EBT3 measurement in heterogeneities. 
This work is supported by the Walloon Region under the project 
name InVivoIGT, convention number 1017266. 
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Purpose/Objective: Currently, pencil beam dose calculation 
algorithms are commonly used in treatment planning for radiotherapy 
with protons. These algorithms are of limited accuracy in some 
situations such as patient heterogeneities, which could be overcome 
when using Monte Carlo (MC) methods. However, MC suffers from long 
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computation time. Thus, in order to gain efficiency, a new macro MC 
(MMC) method for proton dose calculations has been developed.  
Materials and Methods: The MMC transport is based on a local to 
global MC approach. For the local simulations GEANT4 has been used. 
These simulations consist of mono-energetic proton pencil beams 
impinging perpendicularly on slabs of different materials (water, air, 
lung, adipose, muscle, spongiosa, cortical bone) as well as of different 
thicknesses. During the local simulation the physical characteristics 
such as lateral displacement, direction distribution and energy loss 
have been scored for primary and secondary particles. Thereby 
multiple scattering, ionization as well as elastic and inelastic 
interactions have been taken into account. The scored data from 
appropriate slabs is then used for the MMC particle transport in the 
global simulation. During this simulation, the energy loss along the 
path between entrance and exit positions of the selected slab is 
calculated. Additionally, the radiation transport of neutrons, also 
based on local simulations, as well as the secondary ions are included 
into the MMC transport for the dose calculations. In order to validate 
the MMC transport, calculated dose distributions using GEANT4 and 
the MMC transport have been compared. For this purpose, dose 
distributions for different mono-energetic proton beams impinging on 
different phantoms including homogeneous and inhomogeneous 
situations as well as on a patient CT data set have been calculated. 
Results: For the calculated integral depth dose curves the agreement 
is better than 1% or 1 mm for all pencil beams and phantoms 
considered. For the dose profiles the agreement is within 1% or 1 mm 
in all phantoms for all energies and depths. The same level of 
agreement is found for the depth dose curves and profiles using a 
broad incident proton beam on the phantoms. The comparison of the 
dose distribution calculated using either GEANT4 or MMC in the 
patient also shows an agreement of within 1% or 1 mm. The efficiency 
of MMC is up to 200 times higher than for GEANT4. 
Conclusions: The agreement found in the comparisons of the 
calculated dose distributions demonstrates that the newly developed 
MMC transport for proton beams is suitable for very accurate and 
efficient dose calculations. In future, the MMC transport will be 
coupled with a beam model in order to allow treatment planning for 
radiotherapy with proton beams. This work was supported by Varian 
Medical Systems.  
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Purpose/Objective: A key challenge of dynamic radiotherapy 
treatment techniques is the difficulty of incorporating intra-fraction 
organ deformation in the dose calculation algorithms to generate 
more accurate and realistic dose distributions. The aim of this study is 
to use Monte Carlo simulation methods to calculate realistic dose 
distributions that include both the continuous deformation of organs 
and the continuous motion of treatment machine components for 
volumetric modulated arc therapy and helical tomotherapy 
treatments. 
Materials and Methods: We have developed a 4D Monte Carlo-based 
calculation method capable of simulating a wide variety of treatment 
techniques without the need to resort to discretisation 
approximations. The method includes full accelerator head simulation 
of TomoTherapy and Elekta accelerators and a realistic representation 
of continuous deformation of organs and continuous motion of 
treatment machine components. This is done via the interactive 
sampling of geometry parameters using a random time variable 
associated to each simulated particle. We have previously presented a 
method to model the continuous motion of treatment machine 
components. In this study, the DOSXYZnrc user code was further 
modified to account for the continuous intra-fraction deformation of 
patient geometry. More specifically, we have implemented two 
methods to update the transport grid densities as a function of time 
and two methods to map the energy deposited in the time dependant 
transport grid back to a reference grid. 
Results: The density mapping method to update the transport grid 
densities as a function of time was found to be superior to the density 
interpolation method when the patient motion is much greater than 
the voxel size. The voxel average method to map the energy 
deposited in the time dependent transport grid back to a reference 
grid was found to be superior to the voxel center method but requires 
the appropriate use of energy/mass corrections factors. Verification 
with a mathematical phantom and measurements with a moving 
phantom show that the methods were appropriately implemented in 
the EGSnrc user codes. 
Conclusions: We have developed a 4D Monte Carlo-based calculation 
method that successfully models continuous deformation of organs 
and continuous motion of machine components.  
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Purpose/Objective: Breathing motion induces artifacts in 3D PET that 
lower the geometric and quantitative accuracy required for treatment 
planning. On the other hand, acquisition of 4D PET typically takes 
much more time. Our purpose was to implement a fast protocol for 4D 
PET/CT acquisition for radiotherapy treatment planning of lung 
tumors. 
Materials and Methods: Radiotherapy technologists (RTT) and nuclear 
medicine technologists (NMT) closely collaborated to develop the 
clinical protocol described below. The RTT is responsible for patient 
positioning and 4D reconstruction of the data, whereas the NMT is 
responsible for the PET/CT acquisition and 3D reconstruction. 
Patients were scanned in treatment position on a flat table top with 
arm and knee support on a Philips PET/CT scanner. An air bellows belt 
(Mayo Clinic) was placed around the upper abdomen to register the 
respiratory signal. The acquisition protocol consisted of 1) a whole 
body 3D CT, 2) a fast whole body 4D PET with a 2 min scan time per 
bed position, identical to our standard 3D PET protocol and 3) a 4D CT 
of the thorax. The PET scan is reconstructed in 4D using the 4D CT for 
attenuation correction for the thorax region; and a regular 3D PET is 
reconstructed from the same data for the whole body scan.  
The 4D PET is subsequently motion compensated (MC). To that end, 
first the patient specific motion pattern is derived from the 4D CT 
using deformable image registration. Subsequently, the deformation is 
compensated in all phases of the 4D PET scan. Finally, summing all 
phase bins results in a 3D MC PET. We determined the SUVmax value in 
the tumor and the size of the dominant tumor region, i.e. the region 
enclosed by the 50% SUVmax region. 
To clinically validate this novel protocol, 20 lung cancer patients were 
included in a feasibility study. Both the logistics and image quality 
were evaluated. 
Results: During protocol development, RTTs became aware of the 
proper handling of a radioactive patient, the importance of instructing 
patients before FDG administration and in keeping a distance 
whenever possible. NMT became aware of the importance of proper 
patient positioning and respiratory monitoring systems. 
The novel 4D-PET/CT procedure took 6 (± 3) min more than a regular 
3D PET/CT acquisition. This is 15-30 min less than a standard 4D 
PET/CT procedure. Compared to 3D PET images (figure 1b) and the 
single phase images (1a), the MC PET images (1c) provided better 
contrast and sharper images. Higher maximum SUV values (up to 25%) 
were detected in the tumor (mean increase 5.44% (SD=7.16)) and the 
apparent size of the tumor was up to 46% smaller (mean 5.47% 
(SD=9.67)). 
Conclusions: A multidisciplinary approach in protocol development 
and image acquisition is essential to derive safe and efficient 
workflows. Our novel 4D PET/CT acquisition protocol saves 15-30 
minutes acquisition time and improved PET image quality. This 
approach can also be implemented for other organs affected by 
respiratory movements such as the liver. 
